Global Rheumatic Disorders Drugs Market Grow at (CAGR) of 4.46% to $80.04 billion in 2024

Global Rheumatic Disorders Drugs Market to 2024 research report covers key diseases of rheumatic disorders, market size, therapy area overview, etiology, Epidemiology Patterns and Forecasts - Prevalence and Patient Segmentation and key marketed products.

Pune, India - February 12, 2019 /MarketersMedia/ —

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry research report added to ReportsnReports online database.
The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying drugs to be developed.

Get Discount on Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854866

This report covers all rheumatic disorders, but there is a particular focus on five key diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus and psoriatic arthritis, as these conditions have the largest pipelines within the therapy area.

The market size for rheumatic disorder therapeutics was $58.97 billion in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 4.46% to $80.04 billion in 2024.

Scope

- How is the rheumatic disorders market landscape expected to change?
- Which drugs will face patent expiry, biosimilar competition and decreasing revenue over the forecast period?
- Overall, there are 1,069 products in the rheumatic disorder pipeline, how does the composition of the pipeline compare with that of the existing market?
- Which molecular targets are most prominent within the pipeline and how do the key indications differ in terms of their pipeline composition?
- The market size for rheumatic disorder therapeutics is expected to grow, from $58.97 billion in 2017 to $80.04 billion in 2024, at a CAGR of 4.46%. Which products will contribute to market growth most, and which will achieve blockbuster status?
- What types of companies are involved in the rheumatic disorder therapy area?
- Will the current market leaders retain their dominance over the forecast period?
- How many strategic consolidations have been completed in the past decade and which types of assets attract the largest deal values?

Reasons to Buy:
This report will allow you to -
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis for the five key indications
- Understand how the patent expiries of the key, blockbuster anti-TNF drugs will affect the Rheumatic Disorder Drug Market
- Identify trends and developments in the rheumatic disorder pipeline and consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates
- Identify which two drug classes will see particularly strong market growth over the forecast period
- See how or if the companies marketing anti-TNF drugs facing patent expiry will be able to offset biosimilar erosion
- Identify commercial opportunities in the rheumatic disorder deal landscape by analyzing trends in licensing and co-development deals

Direct Purchase of Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854866

Table of Contents:
1. Introduction
2. Key Marketed Products
3. Pipeline Landscape Assessment
4. Multi-scenario Market Forecast to 2024
5. Company Analysis and Positioning
6. Strategic Consolidations
7. Appendix

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854866-global-rheumatic-disorders-drugs-market-to-2024-increased-uptake-of-il-inhibitors-and-jak-inhibitors-to-drive-growth-as-tnf-inhibitors-face-patent-expiry.html

Source URL: https://marketersmedia.com/global-rheumatic-disorders-drugs-market-grow-at-cagr-of-446-to-8004-billion-in-2024/481750

Source: MarketersMedia

Release ID: 481750

More News From Entertainment - The World Insiders

Harvey Weinstein wants to move trial out of NYC

Aug 21, 2019

NEW YORK — A lawyer for Harvey Weinstein has asked that the disgraced movie mogul's upcoming criminal trial be moved out of New York City, saying he can't get a fair trial. In a longshot motion filed with the state appellate court on Friday, attorney Arthur Aidala suggested the trial be moved to upstate Albany County or Suffolk County on Long Island. Aidala cited the intense media coverage and the circuslike atmosphere surrounding Weinstein's past court appearances in Manhattan. The 67-year-old Weinstein is charged with raping a woman in 2013 and performing a forcible sex act on a different woman...

Cowboys' Elliott won't face criminal charge in Vegas scuffle

Aug 21, 2019

LAS VEGAS — Dallas Cowboys star running back Ezekiel Elliott won't face criminal charges after scuffling with a music festival security guard in Las Vegas. Prosecutor Steve Wolfson said Tuesday the findings of a police investigation "lacked prosecutorial merit." The NFL said last month that Elliott didn't violate league personal conduct rules and wouldn't face suspension. Elliott was handcuffed but not arrested after police said he pushed a security guard to the ground at the event last May at Las Vegas Motor Speedway. Cellphone video obtained by celebrity website TMZ showed an event staffer stumbling over a parking barrier after...

Could we BE any more excited? 'Friends' fans nuts for merch

Aug 21, 2019

NEW YORK — See your "Friends" on the big screen. Deck out your place with "Friends" decor. Wear your "Friends" as jewelry. Heck, buy the "Friends" Lego set and pretend it's for your kid. If you're a "Friends" superfan, there are lots of ways to celebrate the show's 25th anniversary in September. "It transcends generations," Maryellen Zarakas, a Warner Bros. senior vice president, said of the show that ended in 2004 after 10 seasons. "Everybody still goes through growing up into your 20s when you get your first job, your first heartbreak, your first time your friends really become your...

Calls for action from Twitter after Pogba gets racist abuse

Aug 21, 2019

LONDON — Manchester United defender Harry Maguire called on social media companies to require users to verify their identities after teammate Paul Pogba was targeted on Twitter with racial abuse. Racially offensive tweets about Pogba were posted after his penalty kick was saved in United's 1-1 draw at Wolverhampton Wanderers in the English Premier League on Monday. The 20-time English champions said they "encourage social media companies to take action in these cases" and Maguire offered a solution. "Every account that is opened should be verified by a passport/driving license. Stop these pathetic trolls making numerous accounts to abuse people,"...

Pell's appeal pitted word of former choirboy against priest

Aug 21, 2019

CANBERRA, Australia — Cardinal George Pell's appeal against his convictions for child molestation was largely a question of who the jury should have believed, his accuser or a senior priest whose church role was likened to Pell's bodyguard. Pell's accuser was a 13-year-old choirboy when he alleged that he was abused by then-Melbourne Archbishop Pell at the city's St. Patrick's Cathedral in December 1996 and February 1997. Monsignor Charles Portelli was a master of ceremonies at the 11 a.m. Sunday Masses where the choir sang. A chorister in the 1990s, David Dearing, told police that Portelli, Pell's right-hand man, was...

About Us

The World Insiders brings you exclusive coverage from across the globe in a timely, easy to consume format sourced directly from our regional media partners.

Contact us: sales[at]theworldinsiders.com

Subscribe Now!